RLAY · Relay Therapeutics, Inc. · Debt
$18.04
-0.30 (-1.64%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$4.02B
Shares
219.14M
Volume · Oct 23
529.17K
Avg daily vol (3M)
2.74M
Debt Profile
Completed filing coverage through May 27, 2021Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 4,014,000 | 10-Q filed 2026-08-06 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 26,644,000 | 10-Q filed 2026-08-06 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1812364
CUSIP
75943R102
13F (30d)
24 filings
24 filers
Visit website
Investor relations